NovoCure LimitedNVCRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank83
3Y CAGR+31.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+31.7%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$17.55M-55.4%
2024$39.33M-4.4%
2023$41.13M+435.8%
2022$7.68M+199.2%
2021$-7.74M+37.1%
2020$-12.30M-55.5%
2019$-7.91M+35.5%
2018$-12.27M-33.8%
2017$-9.17M-49.2%
2016$-6.15M-